Stock Region Penny Picks
Stock Region Penny Picks Newsletter - September 10th, 2024
Stock Region Penny Picks Newsletter - September 10th, 2024
Disclaimer: This newsletter is for informational purposes only and should not be considered as financial advice. Readers should conduct their own research before making any investment decisions.
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
$SKYX - SKYX Platforms
Roth MKM has initiated coverage on SKYX Platforms with a Buy rating and set a price target of $2. Keep an eye on this stock for potential growth opportunities.
$BKYI - BIO-key International
BIO-key International has secured a significant order from a leading government defense ministry, totaling $500K for its biometric user authentication solutions. This follow-on order underscores the company's strength in the cybersecurity space.
$ZAPP - Zapp EV
Zapp EV has successfully completed homologation in Thailand for its i300 model, paving the way for sales in a new market. This expansion could boost the company's presence in the electric vehicle industry.
$XCH - XCharge
XCharge is making its public debut today with an IPO pricing at $9.31. As a global leader in integrated EV charging solutions, XCharge is poised to capture significant market share through innovative technology.
$AILE - iLearningEngines
iLearningEngines CEO Harish Chidambaran addresses recent short-seller claims, emphasizing the company's strong track record and innovation in AI for enterprise learning. This statement aims to reassure investors of the company's robust foundation.
$FTCI - FTC Solar
FTC Solar has announced a multi-year tracker supply agreement with Strata Clean Energy. This partnership highlights FTC Solar's continued growth in the solar energy sector.
$MIRA - Mira Pharmaceuticals
Mira Pharmaceuticals has selected neuropathic pain as the indication for its upcoming Ketamir-2 drug and has submitted a Pre-IND meeting request to the FDA. This development marks a critical step in the company's drug approval process.
Disclaimer: This newsletter is for informational purposes only and is not financial advice. Please ensure you conduct thorough research and consult with financial advisors before making investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net